View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

ICU Medical Announces Time of First Quarter 2024 Earnings Conference C...

ICU Medical Announces Time of First Quarter 2024 Earnings Conference Call SAN CLEMENTE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2024 earnings release and conference call. The Company will release its first quarter 2024 results on Tuesday, May 7th, 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Tuesday, May 7th, 2024. The cal...

 PRESS RELEASE

ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor...

ICU Medical to Present at the KeyBanc Life Sciences & MedTech Investor Forum SAN CLEMENTE, Calif., March 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the KeyBanc Life Sciences & MedTech Investor Forum being held virtually March 19-20, 2024. ICU Medical’s presentation will be on Wednesday, March 20, 2024 at 11:15 a.m. PT (2:15 p.m. ET). Company management will also be participating in one-on-one meetings on Wednesday, March 20, 2024. The pr...

 PRESS RELEASE

ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional ...

ICU Medical to Present at the Raymond James 45ᵗʰ Annual Institutional Investors Conference SAN CLEMENTE, Calif., March 01, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 45th Annual Institutional Investors Conference being held in Orlando, Florida, March 3-6, 2024. ICU Medical’s presentation will be on Monday, March 4, 2024 at 4:30 a.m. PT (7:30 a.m. ET). Company management will also be participating in one-on-one meetings o...

 PRESS RELEASE

ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal ...

ICU Medical Announces Fourth Quarter 2023 Results and Provides Fiscal Year 2024 Guidance SAN CLEMENTE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2023. Fourth Quarter 2023 Results Fourth quarter 2023 revenue was $587.9 million, compared to $578.0 million in the same period in the prior year. GAAP gross profit for the fourth quarter of 2023 was $171.6 million, as compared to $174.9 million in the...

 PRESS RELEASE

ICU Medical Announces Time of Fourth Quarter 2023 Earnings Conference ...

ICU Medical Announces Time of Fourth Quarter 2023 Earnings Conference Call SAN CLEMENTE, Calif., Feb. 13, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq: ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2023 earnings release and conference call. The Company will release its fourth quarter 2023 results on Tuesday, February 27th, 2024 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Tuesday, February 27t...

ICU Medical, Inc.: Slow deleveraging reflecting ongoing challenges to ...

Our credit view of this issuer reflects its attractive margins and its good size and scale, offset by its high financial leverage and elevated regulatory risk.

 PRESS RELEASE

ICU Medical Announces Third Quarter 2023 Results

ICU Medical Announces Third Quarter 2023 Results SAN CLEMENTE, Calif., Nov. 06, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended September 30, 2023. Third Quarter 2023 Results Third quarter 2023 revenue was $553.3 million, compared to $597.9 million in the same period last year. GAAP gross profit for the third quarter of 2023 was $183.9 million, as compared to $186.4 million in the same period last year. GAAP gross margin for the third quarte...

 PRESS RELEASE

ICU Medical Announces Time of Third Quarter 2023 Earnings Conference C...

ICU Medical Announces Time of Third Quarter 2023 Earnings Conference Call SAN CLEMENTE, Calif., Oct. 23, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its third quarter 2023 earnings release and conference call. The Company will release its third quarter 2023 results on Monday, November 6th, 2023 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Monday, November 6th, 2023. T...

 PRESS RELEASE

ICU Medical to Participate at the Morgan Stanley 21st Annual Global He...

ICU Medical to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference SAN CLEMENTE, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a fireside chat at the Morgan Stanley Annual Global Healthcare Conference at 4:30 a.m. PT (7:30 a.m. ET) on Tuesday, September 12, 2023. Company management will also be participating in one-on-one meetings on Tuesday, September 12, 2023. The fireside chat will be webcast ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

 PRESS RELEASE

ICU Medical Announces Second Quarter 2023 Results and Narrows Fiscal Y...

ICU Medical Announces Second Quarter 2023 Results and Narrows Fiscal Year 2023 Guidance Ranges SAN CLEMENTE, Calif., Aug. 07, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended June 30, 2023. Second Quarter 2023 Results Second quarter 2023 revenue was $549.3 million, compared to $561.0 million in the same period last year. GAAP gross profit for the second quarter of 2023 was $192.3 million, as compared to $167.6 million in t...

 PRESS RELEASE

ICU Medical Announces Time of Second Quarter 2023 Earnings Conference ...

ICU Medical Announces Time of Second Quarter 2023 Earnings Conference Call SAN CLEMENTE, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its second quarter 2023 earnings release and conference call. The Company will release its second quarter 2023 results on Monday, August 7th, 2023 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Monday, August 7th, 2023. ...

 PRESS RELEASE

ICU Medical Announces First Quarter 2023 Results

ICU Medical Announces First Quarter 2023 Results SAN CLEMENTE, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended March 31, 2023. First Quarter 2023 Results First quarter 2023 revenue was $568.6 million, compared to $543.1 million in the same period last year. GAAP gross profit for the first quarter of 2023 was $192.0 million, as compared to $168.8 million in the same period last year. GAAP gross margin for the first quarter of ...

 PRESS RELEASE

ICU Medical Announces Time of First Quarter 2023 Earnings Conference C...

ICU Medical Announces Time of First Quarter 2023 Earnings Conference Call SAN CLEMENTE, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its first quarter 2023 earnings release and conference call. The Company will release its first quarter 2023 results on Monday, May 8th, 2023 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Monday, May 8th, 2023. The call c...

 PRESS RELEASE

ICU Medical to Participate at the KeyBanc Life Sciences & MedTech Inve...

ICU Medical to Participate at the KeyBanc Life Sciences & MedTech Investor Forum SAN CLEMENTE, Calif., March 09, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will participate in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum at 7:30 a.m. PT (10:30 a.m. ET) on Wednesday, March 22, 2023. Company management will also be participating in one-on-one meetings on Wednesday, March 22, 2023. The fireside chat will be webcast live and...

 PRESS RELEASE

ICU Medical Announces Fourth Quarter 2022 Results and Provides Fiscal ...

ICU Medical Announces Fourth Quarter 2022 Results and Provides Fiscal Year 2023 Guidance SAN CLEMENTE, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarter ended December 31, 2022. Fourth Quarter 2022 Results Fourth quarter 2022 revenue was $578.0 million, compared to $340.5 million in the same period last year. GAAP gross profit for the fourth quarter of 2022 was $174.9 million, as compared to $127.5 million in the same pe...

 PRESS RELEASE

ICU Medical to Present at the Raymond James 44th Annual Institutional ...

ICU Medical to Present at the Raymond James 44th Annual Institutional Investors Conference SAN CLEMENTE, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced that Company management will present at the Raymond James 44th Annual Institutional Investors Conference being held in Orlando, Florida, March 5-8, 2023. ICU Medical’s presentation will be on Monday, March 6, 2023 at 8:00 a.m. PT (11:00 a.m. ET). Company management will also be participating in one-on-one meetings o...

 PRESS RELEASE

ICU Medical Announces Time of Fourth Quarter 2022 Earnings Conference ...

ICU Medical Announces Time of Fourth Quarter 2022 Earnings Conference Call SAN CLEMENTE, Calif., Feb. 13, 2023 (GLOBE NEWSWIRE) --  ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced the time of its fourth quarter 2022 earnings release and conference call. The Company will release its fourth quarter 2022 results on Monday, February 27th, 2023 at approximately 4:00 p.m. ET (1:00 p.m. PT) and will be conducting a conference call concerning those results at 4:30 p.m. ET (1:30 p.m. PT) on Monday, February 27th,...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

ICU Medical, Inc.: Unexpected integration challenges and cost headwind...

Our credit view of this issuer reflects its attractive margins and its high proportion of recurring revenue, constrained by its high financial leverage and elevated regulatory risk.

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch